Look for:

Our offer for

VERTEX PHARMACEUTICALS INC.


ISIN:
US92532F1003
WKN:
92532F100

2022/12/05 22:00:00
Price
317.60 USD
Difference -1.17% (-3.77)

General attributes

ISINUS92532F1003
SymbolVRTX
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)77,665 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)315.00 USD (100)
Ask (Ask size)321.20 USD (100)
Open318.85 USD
High319.69 USD
Low315.55 USD
Close (prev. day)321.37 USD
VWAP317.541933 USD
Volume (pcs)812,855
Trading volume258,081,804.84
Number of trades23,641
Last size141,867

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: VERTEX PHARMACEUTICALS INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/12/05 22:00:00
Price
317.60 USD
Difference -1.17% (-3.77)

General attributes

ISINUS92532F1003
SymbolVRTX
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)77,665 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)315.00 USD (100)
Ask (Ask size)321.20 USD (100)
Open318.85 USD
High319.69 USD
Low315.55 USD
Close (prev. day)321.37 USD
VWAP317.541933 USD
Volume (pcs)812,855
Trading volume258,081,804.84
Number of trades23,641
Last size141,867

Performance and Risk

6m1Y3Y
Perf (%)+19.65%+67.08%+50.84%
Perf (abs.)+49.65+121.39+101.90
Beta0.640.640.74
Volatility33.2131.2635.55
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)318.49 USD (2,294,132)
Ø price 30 days | Ø volume 30 days (pcs.)311.27 USD (1,667,736)
Ø price 100 days | Ø volume 100 days (pcs.)295.80 USD (1,429,223)
Ø price 250 days | Ø volume 250 days (pcs.)268.69 USD (1,598,873)
YTD High | date323.61 USD (2022/11/23)
YTD Low | date214.66 USD (2022/01/03)
52 Weeks High | date323.61 USD (2022/11/23)
52 Weeks Low | date203.04 USD (2021/12/06)

All listings for VERTEX PHARMACEUTICALS INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/12/0517:35302.40 EUR0.038
Vienna Stock Exchange2022/12/0609:05302.75 EUR0.001
Tradegate2022/12/0609:07302.15 EUR0.002
Stuttgart2022/12/0611:45301.75 EUR0.004
Nasdaq2022/12/0522:00317.60 USD258.0823,641
Munich2022/12/0608:02302.25 EUR0.001
London Stock Exchange2022/12/0215:30317.40 USD0.044
Hanover2022/12/0610:39303.70 EUR0.002
Hamburg2022/12/0608:05302.30 EUR0.001
Frankfurt2022/12/0608:00302.30 EUR0.001
Duesseldorf2022/12/0610:30302.95 EUR0.003
Berlin2022/12/0608:08302.30 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=15368&ID_TYPE_IMAGE_LOGO=2

Contact Details

VERTEX PHARMACEUTICALS INC.
- -
50 Northern Avenue - 02210 Boston
Telefon: 1-617-341-6100
Fax: -
E-mail: mediainfo@vrtx.com

PDF Downloads

Company report: VERTEX PHARMACEUTICALS INC.PDF Download

Company Profile

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Members of Management Board

Jeffrey LeidenChairman of Board of Directors
Alan GarberMember of Board of Directors
Sangeeta BhatiaMember of Board of Directors
Bruce SachsMember of Board of Directors
Diana McKenzieMember of Board of Directors
Lloyd CarneyMember of Board of Directors
Margaret McGlynnMember of Board of Directors
Suketu UpadhyayMember of Board of Directors
Terrence KearneyMember of Board of Directors
Yuchun LeeMember of Board of Directors
Reshma KewalramaniChairman of Managing Board
Bastiano SannaMember of Executive Committee
Carmen BozicMember of Executive Committee
David AltshulerMember of Executive Committee
Edward AtkinsonMember of Executive Committee
Mark BunnageMember of Executive Committee
Nia TatsisMember of Executive Committee
Amit SachdevMember of Executive Committee
Catherine RuttenMember of Executive Committee
Charles WagnerMember of Executive Committee
Damian WilmotMember of Executive Committee
Jonathan BillerMember of Executive Committee
Joy LiuMember of Executive Committee
Kristen AmbroseMember of Executive Committee
Ludovic FenauxMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer